Enzymatic Fat Base Composition for Infant Formula
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current infant formulas do not effectively mimic the triglyceride composition of human milk, leading to reduced absorption of palmitic acid and calcium, resulting in energy and calcium loss, and constipation issues in formula-fed infants, due to the incorrect positional distribution of fatty acids in triglycerides.
Innovation Solution
A novel enzymatically prepared fat base composition with up to 70% of palmitic acid residues at the sn-2 position and a high percentage of unsaturated fatty acids at the sn-1 and sn-3 positions, closely mimicking the triglyceride structure of human breast milk, is developed, along with a process involving reacting palmitic acid-rich oils with unsaturated fatty acids in the presence of an insoluble catalyst, followed by distillation and bleaching, to create a substitute human milk fat composition for infant formulas.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If vegetable oils with palmitic acid at sn-1 and sn-3 positions are used in infant formulas, then the manufacturing cost is reduced and ease of manufacture is improved, but the absorption of palmitic acid and calcium is reduced, leading to energy and calcium loss
Solution Approach 1:
The invention applies local quality by specifically positioning palmitic acid at the sn-2 position of triglycerides, creating a localized structural feature that mimics human milk fat. This positional specificity ensures that palmitic acid is released as a monoglyceride during digestion, preventing calcium soap formation and improving absorption, while other positions (sn-1 and sn-3) are occupied by unsaturated fatty acids.
Solution Approach 2:
The invention uses copying by creating a triglyceride structure that replicates the natural configuration of human milk fat, where palmitic acid is predominantly at the sn-2 position. This copied structure enables formula-fed infants to absorb palmitic acid and calcium efficiently, matching the nutritional benefits of breastfed infants without requiring actual breast milk.
2Ease of manufacture
If palmitic acid is esterified at sn-1 and sn-3 positions in infant formulas, then the manufacturing process is simpler, but constipation occurs and calcium absorption is reduced
Solution Approach 1:
The invention applies local quality by specifically positioning palmitic acid at the sn-2 position of triglycerides, creating a localized structural feature that mimics human milk fat. This positional specificity ensures that palmitic acid is released as a monoglyceride during digestion, preventing calcium soap formation and improving absorption, while other positions (sn-1 and sn-3) are occupied by unsaturated fatty acids.
Solution Approach 2:
The invention converts the potentially harmful effect of palmitic acid (which can form insoluble calcium soaps and cause constipation when at sn-1/sn-3 positions) into a beneficial effect by repositioning it to the sn-2 position. This transformation allows palmitic acid to be released as an absorbable monoglyceride, preventing soap formation and eliminating constipation while maintaining adequate calcium absorption.
3Loss of substance
If human milk fat composition is exactly replicated, then the absorption of palmitic acid and calcium is maximized, but the cost of production increases and safety concerns arise from animal-derived fats
Solution Approach 1:
The invention uses copying by creating a triglyceride structure that replicates the natural configuration of human milk fat, where palmitic acid is predominantly at the sn-2 position. This copied structure enables formula-fed infants to absorb palmitic acid and calcium efficiently, matching the nutritional benefits of breastfed infants without requiring actual breast milk.
Solution Approach 2:
The invention applies parameter changes by modifying the fatty acid composition parameters of vegetable-based oils through enzymatic interesterification. The process achieves sn-2 palmitic acid content of 40-70% and total palmitic acid content of 20-35%, creating a parameter profile that mimics human milk fat while using safe, vegetarian ingredients.
4Manufacturing precision
If enzymatic interesterification is used to position palmitic acid at sn-2 position, then the positional distribution is improved, but the process complexity increases
Solution Approach 1:
The invention applies mechanics substitution by replacing complex chemical interesterification processes with enzymatic interesterification using lipases. This biological catalyst approach achieves precise sn-2 positioning of palmitic acid through enzyme specificity rather than mechanical mixing or chemical reactions, simplifying the overall process control while improving manufacturing precision.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This composition enhances the absorption of palmitic acid and calcium, ensuring optimal energy and calcium intake, reducing constipation and improving overall nutritional benefits for infants, while being cost-effective and safe, without the need for genetically modified enzymes or solvents.
Implementation Method 1
The pancreatic lipase system attacks the triglyceride with a high degree of positional specificity. Lipolysis occurs predominantly at the sn-1 and sn-3 positions, yielding two free fatty acids and a 2-monoglyceride
Implementation Method 2
This initial lipolysis allows maximal activity of pancreatic colipase-dependent lipase during the intestinal phase of digestion
Implementation Method 3
Several studies have demonstrated the preferential absorption of palmitic acid when present at the triglyceride sn-2 position
Implementation Method 4
distilling the excess free fatty acids
Implementation Method 5
bleaching the oil
Data Source
AI summary
The invention provides an enzymatically-prepared fat base composition which comprises a mixture of vegetable-derived triglycerides. The fat base composition has a total palmitic acid residues content of at most 38% of the total fatty acid residues, and at least 60%, preferably 62% of the fatty acid moieties at the sn-2 position of the glycerol backbone are palmitic acid residues, at least 70% of the fatty acid moieties at the sn-1 and sn-3 positions of the glycerol backbone are unsaturated, at least 40%, preferably 40-60%, of the unsaturated fatty acid moieties at the sn-1 and sn-3 positions are oleic acid moieties, and at least 6%, preferably 6-17%, of the unsaturated fatty acid moieties at the sn-1 and sn-3 positions are linoleic acid moieties. The invention also provides preparation and various uses of the fat base composition in the field of infant nutrition.